Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Li-Fraumeni Syndrome 1 Glioma 1 Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 22 Temozolomide 17 Specimen Handling 13 X-Rays 9 Biopsy 9 Radiotherapy 8 Radiation 8 trametinib 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Bevacizumab 6 larotrectinib 4 erdafitinib 4 dabrafenib 4 ulixertinib 3 palbociclib 3 abemaciclib 3 Surgical Procedures, Operative 3 Nivolumab 3 Cyclophosphamide 3 vorasidenib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 olaparib 2 mirdametinib 2 lutetium Lu 177 dotatate 2 ivosidenib 2 fluorodopa F 18 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Diffusion Magnetic Resonance Imaging × 90 days × Clear all

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡